Registry for focused ultrasound treatment in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is a registry that follows people with pancreatic cancer who are scheduled to receive focused ultrasound (FUS). It helps researchers understand how FUS is used and what happens afterward over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 20 years or older
- Sign and date a consent form to join
- Agree to follow the registry rules and be available for the whole study
- Have pancreatic cancer confirmed by tissue testing (biopsy/pathology)
- Have a pancreatic tumor that doctors say can be treated with focused ultrasound (FUS)
- Be able and willing to complete follow-up interviews
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
This trial tests a new ultrasound treatment called Suizenji for people with pancreatic cancer that cannot be removed by surgery. The goal is to see if it can safely target the tumor.
This is a research registry that collects information from adults with pancreatic cancer who are treated with an ablation procedure called irreversible electroporation (IRE). It may help doctors better understand which patients benefit from this approach and how the treatment is used in real life.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This registry collects information about people with advanced pancreatic cancer who are receiving first-line palliative treatment. It helps doctors understand which treatment choices are used and how people do over time.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.